BACKGROUND AND PURPOSE: The natural history of white matter hyperintensity (WMH) progression resulting from normal aging versus comorbid vascular insults remains unclear. Therefore we investigated age-related differences in WMH volumes among a group with comorbid hypertension, abnormal body mass index, and diabetes mellitus to a normal aging group drawn from the same population lacking any of these comorbidities. METHODS: WMH volumes were acquired using 3T MRI for 2011 Dallas Heart Study participants. The slope of the WMH versus age regression was compared between normal and comorbidity groups<50 and ≥50 years of age where a change in slope was demonstrated. RESULTS: Aging was linearly associated with greater log WMH volume for both normal (P=0.02) and comorbidity (P<0.0001) groups. Beyond 50 years of age, more rapid increases in WMH volumes for age were seen in the group with comorbidities (P<0.0001) but not in the normal group (P=0.173). The between-group difference in slope of expected WMH for age was significantly greater in the comorbidity groups≥50 years of age (P=0.0008) but not <50 years of age (P=0.752). CONCLUSIONS: After 50 years of age, but not before, comorbid hypertension, obesity, and diabetes mellitus were associated with significantly larger WMH volumes for age compared with a normal aging group lacking these conditions. These results support the assertion that age-related differences in WMH volumes are significantly increased in the presence of comorbidities, but the effect is only detectable after 50 years of age.
BACKGROUND AND PURPOSE: The natural history of white matter hyperintensity (WMH) progression resulting from normal aging versus comorbid vascular insults remains unclear. Therefore we investigated age-related differences in WMH volumes among a group with comorbid hypertension, abnormal body mass index, and diabetes mellitus to a normal aging group drawn from the same population lacking any of these comorbidities. METHODS:WMH volumes were acquired using 3T MRI for 2011 Dallas Heart Study participants. The slope of the WMH versus age regression was compared between normal and comorbidity groups<50 and ≥50 years of age where a change in slope was demonstrated. RESULTS: Aging was linearly associated with greater log WMH volume for both normal (P=0.02) and comorbidity (P<0.0001) groups. Beyond 50 years of age, more rapid increases in WMH volumes for age were seen in the group with comorbidities (P<0.0001) but not in the normal group (P=0.173). The between-group difference in slope of expected WMH for age was significantly greater in the comorbidity groups≥50 years of age (P=0.0008) but not <50 years of age (P=0.752). CONCLUSIONS: After 50 years of age, but not before, comorbid hypertension, obesity, and diabetes mellitus were associated with significantly larger WMH volumes for age compared with a normal aging group lacking these conditions. These results support the assertion that age-related differences in WMH volumes are significantly increased in the presence of comorbidities, but the effect is only detectable after 50 years of age.
Authors: Keith M Hulsey; Mohit Gupta; Kevin S King; Ronald M Peshock; Anthony R Whittemore; Roderick W McColl Journal: J Magn Reson Imaging Date: 2012-04-19 Impact factor: 4.813
Authors: Frank A Provenzano; Jordan Muraskin; Giuseppe Tosto; Atul Narkhede; Ben T Wasserman; Erica Y Griffith; Vanessa A Guzman; Irene B Meier; Molly E Zimmerman; Adam M Brickman Journal: JAMA Neurol Date: 2013-04 Impact factor: 18.302
Authors: Ronald G Victor; Robert W Haley; DuWayne L Willett; Ronald M Peshock; Patrice C Vaeth; David Leonard; Mujeeb Basit; Richard S Cooper; Vincent G Iannacchione; Wendy A Visscher; Jennifer M Staab; Helen H Hobbs Journal: Am J Cardiol Date: 2004-06-15 Impact factor: 2.778
Authors: Ira Driscoll; Sarah A Gaussoin; Sylvia Wassertheil-Smoller; Marian Limacher; Ramon Casanova; Kristine Yaffe; Susan M Resnick; Mark A Espeland Journal: J Gerontol A Biol Sci Med Sci Date: 2016-03-09 Impact factor: 6.053
Authors: Mark Sanderson-Cimino; Matthew S Panizzon; Jeremy A Elman; Xin Tu; Daniel E Gustavson; Olivia Puckett; Karalani Cross; Randy Notestine; Sean N Hatton; Lisa T Eyler; Linda K McEvoy; Donald J Hagler; Michael C Neale; Nathan A Gillespie; Michael J Lyons; Carol E Franz; Christine Fennema-Notestine; William S Kremen Journal: Neuropsychology Date: 2021-03 Impact factor: 3.295
Authors: Maaike Meurs; Nynke A Groenewold; Annelieke M Roest; Nic J A van der Wee; Dick J Veltman; Marie-José van Tol; Peter de Jonge Journal: Neuroimage Clin Date: 2015-03-28 Impact factor: 4.881
Authors: Kristian L Funck; Esben Laugesen; Pernille Høyem; Brian Stausbøl-Grøn; Won Y Kim; Leif Østergaard; Dora Grauballe; Troels K Hansen; Christian S Buhl; Per L Poulsen Journal: Diabetol Metab Syndr Date: 2021-06-26 Impact factor: 3.320
Authors: Karen Chu; Thao Tran; Ke Wei; Jeanne C Lammering; Anders Sondergaard; Emad Mogadam; Kimberly Shriner; Kevin S King Journal: Open Forum Infect Dis Date: 2018-09-21 Impact factor: 3.835
Authors: Clayton J Vesperman; Vincent Pozorski; Ryan J Dougherty; Lena L Law; Elizabeth Boots; Jennifer M Oh; Catherine L Gallagher; Cynthia M Carlsson; Howard A Rowley; Yue Ma; Barbara B Bendlin; Sanjay Asthana; Mark A Sager; Bruce P Hermann; Sterling C Johnson; Dane B Cook; Ozioma C Okonkwo Journal: Alzheimers Res Ther Date: 2018-09-24 Impact factor: 6.982